600211.SH
西藏药业
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 38.16
−2.13%Sep 1, 2026, 09:12 UTC
Tibet Pharmaceutical announced that as of the end of August 2026, it had repurchased 4,000,058 shares of its own stock, representing 1.24% of total shares, for a total amount of 177,595,651.46 yuan.
Source:Aug 13, 2026, 08:35 UTC
Tibet Rhodiola Pharmaceutical proposed a cash dividend of 1.15 yuan per share (pre-tax) to all shareholders, based on total share capital excluding treasury shares.
Aug 13, 2026, 08:35 UTC
Tibet Rhodiola Pharmaceutical announced its 2026 half-year results: revenue of 1.554 billion yuan, down 5.83% year-on-year; net profit attributable to shareholders of 608 million yuan, up 7.16% year-on-year; non-recurring net profit of 440 million yuan, down 19.00% year-on-year.
Jul 7, 2026, 11:52 UTC
Zhejiang Guyuelongshan Shaoxing Wine Co., Ltd. and Tibet Nuodikang Pharmaceutical Co., Ltd. signed a strategic cooperation agreement to jointly develop a health-oriented special yellow wine.
Source: